Modification of Cystic Fibrosis Phenotypes in the Pancreas and Gut

胰腺和肠道囊性纤维化表型的改变

• 批准号: 238789
• 负责人: Strug Lisa J
• 金额: $ 77.98万
• 依托单位: Hospital for Sick Children (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2011
• 资助国家: 加拿大
• 起止时间: 2011-09-01 至 2016-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=238789&lang=en
• 关键词: Association; Cystic Fibrosis; Diabetes; Gene Modifiers; Heritability; Intestinal Obstruction; Modifiers; Pancreatic Function; Population-Based Study; Statistical Genetics

Cystic Fibrosis (CF) is a fatal, genetic disease affecting 1 in 3600 Canadians. Individuals with CF have a variable course of disease severity as evidenced by individual differences in lung disease and rates of common co-morbidities, all of which affect

囊性纤维化（CF）是一种致命的遗传性疾病，每3600名加拿大人中就有1人受到影响。 CF患者的病程严重程度不同，这可以通过肺部疾病和常见合并症的发生率的个体差异来证明，所有这些都会影响CF的预后。